Garuda Metalindo Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Garuda Metalindo Tbk trades at Rp790 (market cap 1.89T, 16.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Garuda Metalindo Tbk is far larger — about 11.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 16.5K). Which is the better fit depends on your goals.
| BOLT | OBAT | |
|---|---|---|
Market Cap | 1.89T | 167.37B |
Volume | 16.5K | 71K |
Lot | 165 | 710 |
Turnover | 13.01M | 17.51M |
Average Price | 788.24 | 246.63 |
Value | 13.01M | 17.51M |
Indicative Equilibrium Price | 790 | 246 |
Indicative Equilibrium Volume | 26 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Garuda Metalindo Tbk (the Company) was established based on the Notarial Deed No. 28 dated March 15, 1982 of Lenny Budiman, S.H., Notary in Jakarta.
Read more on BOLT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →